FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134911659> ?p ?o ?g. }

• W2134911659 endingPage "148" @default.
• W2134911659 startingPage "144" @default.
• W2134911659 abstract "<h3>OBJECTIVE</h3> To evaluate methotrexate treatment in patients with active adult onset Still’s disease (AOSD). <h3>METHODS</h3> Methotrexate was initially given as a single weekly oral dose of 5 mg and adjusted individually afterwards in 13 patients with active AOSD. Symptoms and laboratory findings were investigated. <h3>RESULTS</h3> Signs of AOSD activity disappeared (remission) in eight patients between 3 and 16 weeks after starting methotrexate. In these patients, significant improvements in C reactive protein, erythrocyte sedimentation rate, white blood count, and serum ferritin were observed at 8, 12, 14, and 16 weeks after starting methotrexate, respectively. In six of these eight patients, steroids or non-steroidal anti-inflammatory drugs could be reduced or discontinued. In four patients methotrexate was not effective despite 12 or 16 weeks of treatment, and one patient discontinued treatment after 2 weeks because of severe nausea. Five patients suffered from adverse reactions, including acute interstitial pneumonia (one patient) and liver toxicity (two patients). Five out of eight patients successfully treated with methotrexate were HLA-DR4 positive (four homozygotes), and all the unsuccessfully treated patients were DR2 positive. <h3>CONCLUSIONS</h3> Methotrexate is useful for controlling disease activity in AOSD, not only for refractory patients but also for patients who have never taken steroids or for those with steroid associated toxicity. However, serious adverse reactions can occur, as with rheumatoid arthritis. It is important to determine the critical factors, such as the immunogenetic background, that are associated with response to methotrexate treatment." @default.
• W2134911659 created "2016-06-24" @default.
• W2134911659 creator A5006497339 @default.
• W2134911659 creator A5016575106 @default.
• W2134911659 creator A5022602325 @default.
• W2134911659 creator A5047674701 @default.
• W2134911659 creator A5057496346 @default.
• W2134911659 creator A5058629132 @default.
• W2134911659 creator A5084010764 @default.
• W2134911659 creator A5085337453 @default.
• W2134911659 date "1997-02-01" @default.
• W2134911659 modified "2023-10-16" @default.
• W2134911659 title "Methotrexate treatment in patients with adult onset Still's disease---retrospective study of 13 Japanese cases" @default.
• W2134911659 cites W124199595 @default.
• W2134911659 cites W130107031 @default.
• W2134911659 cites W1578612512 @default.
• W2134911659 cites W1980597439 @default.
• W2134911659 cites W2031953119 @default.
• W2134911659 cites W2104164819 @default.
• W2134911659 cites W2119577379 @default.
• W2134911659 cites W2158778799 @default.
• W2134911659 cites W2161165639 @default.
• W2134911659 cites W2227912200 @default.
• W2134911659 cites W2332456283 @default.
• W2134911659 cites W2414855593 @default.
• W2134911659 cites W2465740419 @default.
• W2134911659 cites W28288604 @default.
• W2134911659 doi "https://doi.org/10.1136/ard.56.2.144" @default.
• W2134911659 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1752327" @default.
• W2134911659 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9068291" @default.
• W2134911659 hasPublicationYear "1997" @default.
• W2134911659 type Work @default.
• W2134911659 sameAs 2134911659 @default.
• W2134911659 citedByCount "67" @default.
• W2134911659 countsByYear W21349116592012 @default.
• W2134911659 countsByYear W21349116592013 @default.
• W2134911659 countsByYear W21349116592014 @default.
• W2134911659 countsByYear W21349116592015 @default.
• W2134911659 countsByYear W21349116592016 @default.
• W2134911659 countsByYear W21349116592017 @default.
• W2134911659 countsByYear W21349116592018 @default.
• W2134911659 countsByYear W21349116592019 @default.
• W2134911659 countsByYear W21349116592020 @default.
• W2134911659 countsByYear W21349116592021 @default.
• W2134911659 countsByYear W21349116592022 @default.
• W2134911659 countsByYear W21349116592023 @default.
• W2134911659 crossrefType "journal-article" @default.
• W2134911659 hasAuthorship W2134911659A5006497339 @default.
• W2134911659 hasAuthorship W2134911659A5016575106 @default.
• W2134911659 hasAuthorship W2134911659A5022602325 @default.
• W2134911659 hasAuthorship W2134911659A5047674701 @default.
• W2134911659 hasAuthorship W2134911659A5057496346 @default.
• W2134911659 hasAuthorship W2134911659A5058629132 @default.
• W2134911659 hasAuthorship W2134911659A5084010764 @default.
• W2134911659 hasAuthorship W2134911659A5085337453 @default.
• W2134911659 hasBestOaLocation W21349116591 @default.
• W2134911659 hasConcept C121332964 @default.
• W2134911659 hasConcept C126322002 @default.
• W2134911659 hasConcept C141071460 @default.
• W2134911659 hasConcept C142424586 @default.
• W2134911659 hasConcept C197934379 @default.
• W2134911659 hasConcept C2777575956 @default.
• W2134911659 hasConcept C2778143017 @default.
• W2134911659 hasConcept C2778397455 @default.
• W2134911659 hasConcept C2780580376 @default.
• W2134911659 hasConcept C2781059491 @default.
• W2134911659 hasConcept C2781382166 @default.
• W2134911659 hasConcept C29730261 @default.
• W2134911659 hasConcept C71924100 @default.
• W2134911659 hasConcept C87355193 @default.
• W2134911659 hasConcept C90924648 @default.
• W2134911659 hasConceptScore W2134911659C121332964 @default.
• W2134911659 hasConceptScore W2134911659C126322002 @default.
• W2134911659 hasConceptScore W2134911659C141071460 @default.
• W2134911659 hasConceptScore W2134911659C142424586 @default.
• W2134911659 hasConceptScore W2134911659C197934379 @default.
• W2134911659 hasConceptScore W2134911659C2777575956 @default.
• W2134911659 hasConceptScore W2134911659C2778143017 @default.
• W2134911659 hasConceptScore W2134911659C2778397455 @default.
• W2134911659 hasConceptScore W2134911659C2780580376 @default.
• W2134911659 hasConceptScore W2134911659C2781059491 @default.
• W2134911659 hasConceptScore W2134911659C2781382166 @default.
• W2134911659 hasConceptScore W2134911659C29730261 @default.
• W2134911659 hasConceptScore W2134911659C71924100 @default.
• W2134911659 hasConceptScore W2134911659C87355193 @default.
• W2134911659 hasConceptScore W2134911659C90924648 @default.
• W2134911659 hasIssue "2" @default.
• W2134911659 hasLocation W21349116591 @default.
• W2134911659 hasLocation W21349116592 @default.
• W2134911659 hasLocation W21349116593 @default.
• W2134911659 hasLocation W21349116594 @default.
• W2134911659 hasLocation W21349116595 @default.
• W2134911659 hasOpenAccess W2134911659 @default.
• W2134911659 hasPrimaryLocation W21349116591 @default.
• W2134911659 hasRelatedWork W2068695759 @default.
• W2134911659 hasRelatedWork W2150996317 @default.
• W2134911659 hasRelatedWork W2317243404 @default.
• W2134911659 hasRelatedWork W2397887758 @default.

• next